QSIVA Trademark

Trademark Overview

On Monday, December 13, 2010, a trademark application was filed for QSIVA with the United States Patent and Trademark Office. The USPTO has given the QSIVA trademark a serial number of 85196230. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 29, 2014. This trademark is owned by Vivus, Inc.. The QSIVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for treatment and prevention of diseases and conditions in humans; pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders in males and females, for the maintenance of sexual health, for treatment of menopause and post-menopause symptoms and conditions, for treatment of hormonal disorders, for use in the treatment and prevention of endometriosis, osteoporosis, urinary incontinence and infertility, for the treatment of obesity, to facilitate weight loss and weight control, to suppress appetite and lower the threshold for satiety, for treatment of metabolic disorders, for treatment of diabetes, cardiovascular disorders and cardiovascular diseases in humans, and for treatment of sleep disorders and neurodegenerative diseases; contraceptive preparations for use in humans
qsiva

General Information

Serial Number85196230
Word MarkQSIVA
Filing DateMonday, December 13, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 29, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2011

Trademark Statements

Goods and ServicesPharmaceuticals for treatment and prevention of diseases and conditions in humans; pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders in males and females, for the maintenance of sexual health, for treatment of menopause and post-menopause symptoms and conditions, for treatment of hormonal disorders, for use in the treatment and prevention of endometriosis, osteoporosis, urinary incontinence and infertility, for the treatment of obesity, to facilitate weight loss and weight control, to suppress appetite and lower the threshold for satiety, for treatment of metabolic disorders, for treatment of diabetes, cardiovascular disorders and cardiovascular diseases in humans, and for treatment of sleep disorders and neurodegenerative diseases; contraceptive preparations for use in humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 16, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivus, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCampbell, CA 95008
Party NameVivus, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94040

Trademark Events

Event DateEvent Description
Monday, January 30, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 30, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 29, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 29, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, May 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 22, 2014EXTENSION 5 GRANTED
Wednesday, May 21, 2014EXTENSION 5 FILED
Wednesday, May 21, 2014TEAS EXTENSION RECEIVED
Thursday, November 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2013EXTENSION 4 GRANTED
Monday, November 18, 2013EXTENSION 4 FILED
Monday, November 18, 2013TEAS EXTENSION RECEIVED
Tuesday, July 2, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 2, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 17, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2013EXTENSION 3 GRANTED
Wednesday, May 15, 2013EXTENSION 3 FILED
Wednesday, May 15, 2013TEAS EXTENSION RECEIVED
Friday, November 16, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 15, 2012EXTENSION 2 GRANTED
Tuesday, November 13, 2012EXTENSION 2 FILED
Thursday, November 15, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 13, 2012TEAS EXTENSION RECEIVED
Friday, May 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 16, 2012EXTENSION 1 GRANTED
Wednesday, May 16, 2012EXTENSION 1 FILED
Wednesday, May 16, 2012TEAS EXTENSION RECEIVED
Tuesday, November 22, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 27, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2011PUBLISHED FOR OPPOSITION
Monday, August 22, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 16, 2011ASSIGNED TO LIE
Thursday, August 4, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 3, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 3, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 4, 2011NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, February 4, 2011PRIORITY ACTION E-MAILED
Friday, February 4, 2011PRIORITY ACTION WRITTEN
Tuesday, February 1, 2011ASSIGNED TO EXAMINER
Thursday, December 16, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 16, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

qsiva treatment disorders humans diseases weight menopause sexual pharmaceuticals cardiovascular conditions